Fig. 1From: Rational selection of a biomarker panel targeting unmet clinical needs in kidney injuryStrategy for the rational biomarker selection and test development driven by unmet clinical needs in kidney injury. Clinical needs were identified by nephrologists using a peer reviewed EFLM Test Evaluation questionnaire. Subsequently, desirable test roles, test purposes and clinical performance specifications in the clinical pathway were defined. Through a literature study a candidate biomarker panel is proposed that could meet existing gaps in current practice and aims to improve clinical practice and outcome. A multiplex test is in development to enable precision diagnostics in kidney injuryBack to article page